Roche Set To Buy United States Biotech Firm InterMune For $8.3 Billion
There is yet another multibillion-dollar deal in a consolidating pharmaceutical sector, as Roche Holding AG has agreed to buy United States biotech company InterMune Inc for $8.3 billion in cash. Announced this past Sunday, Swiss…